Лечение пациентов с множественным склерозом: факторы риска.
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Rodríguez de Antonio L A, Fernández de Córdoba-García R, Herrero-Muñoz N, Ontañón-Nasarre A, García-Castañón I
Аннотация
Оригинал публикации
Treatment adherence in patients with multiple sclerosis: risk factors.
INTRODUCTION: Adherence is a modifiable factor to disease-modifying treatments response in patients with multiple sclerosis (MS). Our objective is to assess the risk factors associated with inadequate adherence.
METHOD: Retrospective study through review of medical records and review of the database of pharmaceutical dispensing of patients with MS of a tertiary hospital from 2004 to 2022. A multivariate logistic regression analysis of demographic, clinical, nosological, and therapeutic factors was performed between adherent and non-adherent patients and treatments.
RESULT: 546 treatments of 284 patients (67.3% women, age 38.4 ± 10.0) were analysed, observing 87.5% adherence. Non-adherent patients presented a higher EDSS at the end of treatment, were more frequently patients with secondary progressive multiple sclerosis, and had a higher proportion of cognitive impairment, psychiatric pathology, polypharmacy, and alcohol and drug use. After the multivariable analysis, risk factors were cognitive impairment (OR: 3.82 [1.51-9.70], P = .005), and alcohol and drug use (OR: 22.83 [7.32-71.20], P < .001). On the contrary, oral drugs favored better adherence (OR 0.29 [0.12-0.75], P = .01).
CONCLUSIONS: Among many factors, alcohol or drug use and cognitive impairment are the major risk factors for low therapeutic adherence in patients with MS.